BioVie President & CEO Cuong Do joins Natalie Stoberman from the Proactive studio to share the company's latest updates from clinical trials on Alzheimer's and Parkinson's Disease.
BioVie is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. For more information visit https://bioviepharma.com/